Ascendis Pharma A-S
Price & Volume
Stats
See more52W Range | $111.09-$161 |
Market Cap | $8.1B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $317.6M |
Revenue Growth (YoY) | -24% |
Gross Profit (12 Mos) | $39M |
Diluted EPS | -$7.83 |
News
See moreYahoo Finance • 3 months ago
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
Yahoo Finance • 3 months ago
RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc
Yahoo Finance • 3 months ago
Pivotal ApproaCH Trial of TransCon™ CNP (Navepegritide) Achieved Primary Objective, Demonstrated AGV Superior to Placebo
Yahoo Finance • 4 months ago
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 879 |
